Experience
Elibo Health LLC is owned and managed by Dr. Elisabeth Brock. Elisabeth has 20 years of experience in HEOR, HTA and Market Access Consulting for Switzerland, as well as other countries.
Elisabeth's Experience:
- Since 2024 - Owner & Managing Director (Full time), Elibo Health LLC
- 2022-23 - Principal, Value & Payer Evidence, IQVIA (EMEA)
- 2020-22 - Senior Consultant Market Access Switzerland/ Health Economics Europe. HealthEcon AG, Basel, Switzerland
- 2004-2020 - Responsible for projects covering HTA/ HEOR/ Market Access Switzerland (BAG, BSV), Germany (G-BA, IQWiG, InEK), UK (NICE), Sweden (TLV). HealthEcon AG, Basel, Switzerland
Publications
- Steinl, et al. Cost of overweight, obesity, and related complications in Switzerland 2021. Frontiers in Public Health 2024; 12: 1335115
- Brock, et al. Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland. PharmacoEconomics – Open 2022; 6: 735-743
- Moradi-Lakeh, et al. Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland. Adv Ther 2021; 38: 3427-3443
- Brock, et al. Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data. Eur J Health Econ 2014; 15(9): 907-16
- Navarini et al. Estimation of cost-of-illness in patients with psoriasis in Switzerland. Swiss Med Weekly 2009; 140(5-6): 85-91
Education
- PhD Health Economics, University of St Andrews, UK
- MA (Jt. Hons) Economics - Management, University of St Andrews, UK
- Professional Diploma in Coaching and Mentoring, Kingstown College, Ireland
- Integrative Nutrition Health Coach, Institute for Integrative Nutrition (IIN), New York, USA